| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 31 | 2021 | 1085 | 3.920 |
Why?
|
| Veterans | 28 | 2021 | 904 | 3.160 |
Why?
|
| Models, Statistical | 12 | 2021 | 448 | 2.380 |
Why?
|
| Medication Adherence | 17 | 2021 | 335 | 2.200 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2021 | 212 | 2.080 |
Why?
|
| Kidney Transplantation | 16 | 2023 | 839 | 1.730 |
Why?
|
| Hypoglycemic Agents | 13 | 2019 | 362 | 1.540 |
Why?
|
| Aged | 92 | 2022 | 14862 | 1.530 |
Why?
|
| Stroke | 24 | 2020 | 2163 | 1.460 |
Why?
|
| Biometry | 3 | 2020 | 72 | 1.430 |
Why?
|
| Humans | 172 | 2023 | 68618 | 1.410 |
Why?
|
| Bias | 4 | 2020 | 148 | 1.370 |
Why?
|
| Liver Cirrhosis | 3 | 2023 | 301 | 1.320 |
Why?
|
| Male | 129 | 2022 | 37321 | 1.320 |
Why?
|
| Female | 129 | 2022 | 38074 | 1.300 |
Why?
|
| Residence Characteristics | 3 | 2020 | 252 | 1.270 |
Why?
|
| Medicare | 9 | 2022 | 319 | 1.210 |
Why?
|
| Retrospective Studies | 48 | 2023 | 7277 | 1.200 |
Why?
|
| Middle Aged | 99 | 2022 | 21147 | 1.130 |
Why?
|
| United States | 46 | 2022 | 7367 | 1.120 |
Why?
|
| Social Determinants of Health | 5 | 2020 | 96 | 1.110 |
Why?
|
| Longitudinal Studies | 22 | 2022 | 1054 | 1.090 |
Why?
|
| Diabetes Mellitus | 9 | 2019 | 694 | 1.070 |
Why?
|
| Cohort Studies | 24 | 2021 | 2358 | 1.040 |
Why?
|
| Delivery of Health Care | 5 | 2022 | 445 | 1.030 |
Why?
|
| Tomography, X-Ray Computed | 21 | 2020 | 2324 | 0.990 |
Why?
|
| Regression Analysis | 5 | 2015 | 737 | 0.990 |
Why?
|
| Data Interpretation, Statistical | 3 | 2017 | 329 | 0.980 |
Why?
|
| Telemedicine | 7 | 2021 | 700 | 0.970 |
Why?
|
| Hypertension | 14 | 2020 | 1535 | 0.960 |
Why?
|
| United States Department of Veterans Affairs | 12 | 2020 | 307 | 0.960 |
Why?
|
| Adult | 74 | 2023 | 21403 | 0.960 |
Why?
|
| Mortality | 5 | 2018 | 163 | 0.890 |
Why?
|
| Drug Prescriptions | 3 | 2019 | 135 | 0.890 |
Why?
|
| Health Status Disparities | 6 | 2020 | 326 | 0.880 |
Why?
|
| Lung Neoplasms | 11 | 2022 | 1173 | 0.870 |
Why?
|
| Dyslipidemias | 3 | 2020 | 98 | 0.870 |
Why?
|
| Coronary Angiography | 10 | 2014 | 866 | 0.870 |
Why?
|
| Warfare | 2 | 2022 | 58 | 0.860 |
Why?
|
| Case-Control Studies | 13 | 2020 | 1553 | 0.860 |
Why?
|
| Veterans Health | 2 | 2020 | 62 | 0.840 |
Why?
|
| Transaminases | 1 | 2022 | 21 | 0.800 |
Why?
|
| Malnutrition | 1 | 2022 | 28 | 0.790 |
Why?
|
| Healthcare Disparities | 8 | 2023 | 378 | 0.780 |
Why?
|
| Ethiopia | 6 | 2022 | 16 | 0.770 |
Why?
|
| Cardiovascular Diseases | 5 | 2020 | 940 | 0.760 |
Why?
|
| Aged, 80 and over | 25 | 2020 | 4848 | 0.760 |
Why?
|
| Health Personnel | 3 | 2022 | 286 | 0.720 |
Why?
|
| Risk Factors | 37 | 2022 | 5731 | 0.710 |
Why?
|
| Early Detection of Cancer | 8 | 2022 | 454 | 0.710 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 161 | 0.700 |
Why?
|
| Environmental Exposure | 2 | 2019 | 269 | 0.670 |
Why?
|
| Hospitalization | 7 | 2021 | 978 | 0.660 |
Why?
|
| DDT | 1 | 2019 | 19 | 0.650 |
Why?
|
| Nigeria | 12 | 2022 | 35 | 0.650 |
Why?
|
| Poisson Distribution | 2 | 2016 | 85 | 0.640 |
Why?
|
| Multimorbidity | 1 | 2018 | 7 | 0.630 |
Why?
|
| Intracranial Hemorrhages | 4 | 2020 | 80 | 0.630 |
Why?
|
| Geographic Mapping | 1 | 2018 | 19 | 0.630 |
Why?
|
| Blood Pressure | 10 | 2020 | 1451 | 0.620 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 334 | 0.620 |
Why?
|
| Coronary Disease | 3 | 2014 | 358 | 0.590 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2022 | 504 | 0.580 |
Why?
|
| Risk Assessment | 10 | 2022 | 2007 | 0.570 |
Why?
|
| Dementia | 1 | 2019 | 158 | 0.570 |
Why?
|
| Environmental Pollutants | 1 | 2019 | 180 | 0.560 |
Why?
|
| Health Surveys | 3 | 2016 | 489 | 0.560 |
Why?
|
| Demography | 2 | 2018 | 279 | 0.550 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2014 | 125 | 0.550 |
Why?
|
| Research | 1 | 2017 | 214 | 0.550 |
Why?
|
| Self Care | 5 | 2019 | 253 | 0.550 |
Why?
|
| Odds Ratio | 10 | 2019 | 880 | 0.530 |
Why?
|
| Comorbidity | 13 | 2019 | 1426 | 0.520 |
Why?
|
| Likelihood Functions | 3 | 2021 | 106 | 0.510 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2019 | 767 | 0.510 |
Why?
|
| Brain | 6 | 2020 | 2176 | 0.500 |
Why?
|
| Paranasal Sinuses | 1 | 2016 | 165 | 0.480 |
Why?
|
| Ghana | 12 | 2020 | 40 | 0.470 |
Why?
|
| Young Adult | 24 | 2022 | 5717 | 0.470 |
Why?
|
| Atherosclerosis | 1 | 2016 | 204 | 0.470 |
Why?
|
| Data Collection | 4 | 2020 | 420 | 0.470 |
Why?
|
| Graft Survival | 7 | 2018 | 465 | 0.460 |
Why?
|
| Hospitals, Veterans | 4 | 2020 | 147 | 0.460 |
Why?
|
| Logistic Models | 8 | 2020 | 1420 | 0.460 |
Why?
|
| Depression | 5 | 2016 | 943 | 0.460 |
Why?
|
| Mass Screening | 6 | 2020 | 843 | 0.460 |
Why?
|
| Transplant Recipients | 4 | 2019 | 109 | 0.450 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 565 | 0.450 |
Why?
|
| Graft Rejection | 7 | 2021 | 458 | 0.450 |
Why?
|
| Primary Health Care | 6 | 2023 | 703 | 0.440 |
Why?
|
| Smartphone | 3 | 2018 | 69 | 0.430 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 786 | 0.420 |
Why?
|
| Cross-Sectional Studies | 10 | 2022 | 2279 | 0.410 |
Why?
|
| Pharmacists | 3 | 2021 | 125 | 0.410 |
Why?
|
| Kidney Failure, Chronic | 3 | 2023 | 365 | 0.390 |
Why?
|
| Computer Simulation | 7 | 2021 | 706 | 0.390 |
Why?
|
| HIV Infections | 4 | 2021 | 791 | 0.380 |
Why?
|
| Adolescent | 24 | 2022 | 8912 | 0.380 |
Why?
|
| Emergency Service, Hospital | 5 | 2020 | 711 | 0.380 |
Why?
|
| Sexual Partners | 3 | 2021 | 106 | 0.380 |
Why?
|
| Substance-Related Disorders | 3 | 2021 | 1242 | 0.370 |
Why?
|
| Sinusitis | 1 | 2016 | 432 | 0.370 |
Why?
|
| Pregnant Women | 2 | 2021 | 50 | 0.370 |
Why?
|
| Smoking Cessation | 4 | 2022 | 1034 | 0.360 |
Why?
|
| Education | 1 | 2011 | 83 | 0.360 |
Why?
|
| Heterosexuality | 2 | 2020 | 17 | 0.360 |
Why?
|
| Attitude | 1 | 2011 | 121 | 0.350 |
Why?
|
| Brain Ischemia | 5 | 2019 | 665 | 0.350 |
Why?
|
| Cost of Illness | 3 | 2017 | 206 | 0.350 |
Why?
|
| Time Factors | 14 | 2020 | 4655 | 0.350 |
Why?
|
| Intimate Partner Violence | 2 | 2021 | 58 | 0.350 |
Why?
|
| Faculty, Medical | 1 | 2011 | 110 | 0.350 |
Why?
|
| Blood Glucose | 6 | 2016 | 631 | 0.340 |
Why?
|
| Interprofessional Relations | 1 | 2011 | 188 | 0.330 |
Why?
|
| Health Care Costs | 6 | 2016 | 346 | 0.320 |
Why?
|
| Information Dissemination | 2 | 2020 | 113 | 0.320 |
Why?
|
| Immunosuppressive Agents | 6 | 2021 | 514 | 0.320 |
Why?
|
| Prognosis | 9 | 2020 | 2093 | 0.320 |
Why?
|
| Severity of Illness Index | 8 | 2023 | 1851 | 0.310 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2017 | 627 | 0.310 |
Why?
|
| Coronary Stenosis | 4 | 2014 | 246 | 0.310 |
Why?
|
| Motor Activity | 3 | 2020 | 621 | 0.310 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2020 | 2223 | 0.310 |
Why?
|
| Motivational Interviewing | 2 | 2021 | 40 | 0.310 |
Why?
|
| Health Behavior | 3 | 2019 | 458 | 0.300 |
Why?
|
| Diabetes, Gestational | 3 | 2013 | 81 | 0.300 |
Why?
|
| Linear Models | 6 | 2015 | 521 | 0.300 |
Why?
|
| Melanoma | 2 | 2022 | 335 | 0.300 |
Why?
|
| Multiple Myeloma | 4 | 2010 | 92 | 0.300 |
Why?
|
| Obesity | 5 | 2020 | 1076 | 0.290 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2019 | 140 | 0.290 |
Why?
|
| South Carolina | 15 | 2021 | 2752 | 0.290 |
Why?
|
| Skin Neoplasms | 2 | 2022 | 375 | 0.290 |
Why?
|
| Cerebral Hemorrhage | 2 | 2020 | 198 | 0.290 |
Why?
|
| Prevalence | 10 | 2020 | 1619 | 0.280 |
Why?
|
| Health Services Accessibility | 4 | 2021 | 581 | 0.280 |
Why?
|
| Patient Education as Topic | 3 | 2019 | 425 | 0.280 |
Why?
|
| Treatment Outcome | 9 | 2022 | 7029 | 0.280 |
Why?
|
| Dyslexia | 2 | 2017 | 17 | 0.280 |
Why?
|
| Antihypertensive Agents | 4 | 2020 | 498 | 0.280 |
Why?
|
| Brain Injuries | 3 | 2015 | 268 | 0.270 |
Why?
|
| Incidence | 10 | 2022 | 1603 | 0.270 |
Why?
|
| Multivariate Analysis | 6 | 2020 | 1046 | 0.270 |
Why?
|
| Artifacts | 3 | 2012 | 125 | 0.270 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 6 | 2014 | 373 | 0.260 |
Why?
|
| Mexican Americans | 2 | 2019 | 30 | 0.260 |
Why?
|
| Social Class | 3 | 2016 | 127 | 0.260 |
Why?
|
| Child | 10 | 2022 | 6405 | 0.260 |
Why?
|
| Government Programs | 2 | 2022 | 16 | 0.250 |
Why?
|
| Biomarkers | 3 | 2020 | 1593 | 0.250 |
Why?
|
| Fibrosis | 3 | 2023 | 371 | 0.250 |
Why?
|
| Living Donors | 2 | 2018 | 160 | 0.250 |
Why?
|
| Hospitals | 5 | 2022 | 265 | 0.250 |
Why?
|
| Genetics, Population | 1 | 2004 | 21 | 0.250 |
Why?
|
| Income | 5 | 2018 | 167 | 0.240 |
Why?
|
| Haplotypes | 1 | 2004 | 174 | 0.240 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 188 | 0.240 |
Why?
|
| Depressive Disorder | 1 | 2008 | 621 | 0.240 |
Why?
|
| Tobacco Use Disorder | 2 | 2020 | 432 | 0.240 |
Why?
|
| Nutrition Surveys | 2 | 2019 | 208 | 0.240 |
Why?
|
| Models, Genetic | 1 | 2004 | 161 | 0.230 |
Why?
|
| Socioeconomic Factors | 7 | 2020 | 955 | 0.230 |
Why?
|
| Mental Disorders | 3 | 2015 | 659 | 0.230 |
Why?
|
| Algorithms | 7 | 2014 | 1196 | 0.230 |
Why?
|
| Mobile Applications | 3 | 2021 | 138 | 0.230 |
Why?
|
| Attitude to Health | 3 | 2013 | 403 | 0.230 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 277 | 0.220 |
Why?
|
| Bayes Theorem | 2 | 2015 | 307 | 0.220 |
Why?
|
| Blood Glucose Self-Monitoring | 4 | 2018 | 62 | 0.220 |
Why?
|
| Heart Failure | 3 | 2018 | 1180 | 0.220 |
Why?
|
| Survival Rate | 7 | 2020 | 1056 | 0.210 |
Why?
|
| Altruism | 1 | 2022 | 24 | 0.210 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2020 | 756 | 0.210 |
Why?
|
| Nutrition Assessment | 1 | 2022 | 43 | 0.210 |
Why?
|
| Proportional Hazards Models | 8 | 2018 | 792 | 0.210 |
Why?
|
| Surveys and Questionnaires | 6 | 2020 | 2800 | 0.210 |
Why?
|
| Stroke Rehabilitation | 2 | 2017 | 335 | 0.210 |
Why?
|
| Survival Analysis | 5 | 2018 | 714 | 0.210 |
Why?
|
| Urban Health | 2 | 2020 | 49 | 0.210 |
Why?
|
| Cost Savings | 2 | 2021 | 110 | 0.210 |
Why?
|
| Minority Groups | 3 | 2020 | 197 | 0.210 |
Why?
|
| Rural Health | 2 | 2020 | 66 | 0.210 |
Why?
|
| Lung | 4 | 2022 | 849 | 0.210 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 498 | 0.200 |
Why?
|
| Pregnancy in Diabetics | 2 | 2013 | 70 | 0.200 |
Why?
|
| Nutritional Status | 1 | 2022 | 112 | 0.200 |
Why?
|
| Medicaid | 2 | 2021 | 302 | 0.200 |
Why?
|
| Birth Weight | 2 | 2013 | 186 | 0.200 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 87 | 0.200 |
Why?
|
| Health Facilities | 1 | 2021 | 36 | 0.200 |
Why?
|
| Psychotic Disorders | 2 | 2014 | 157 | 0.190 |
Why?
|
| Computer-Assisted Instruction | 2 | 2013 | 74 | 0.190 |
Why?
|
| Tacrolimus | 3 | 2021 | 127 | 0.190 |
Why?
|
| Pregnancy | 8 | 2021 | 2334 | 0.190 |
Why?
|
| Pharmacology, Clinical | 1 | 2021 | 13 | 0.190 |
Why?
|
| Smoking | 4 | 2018 | 1452 | 0.190 |
Why?
|
| Sex Factors | 3 | 2020 | 1266 | 0.190 |
Why?
|
| Coronary Artery Disease | 3 | 2012 | 696 | 0.190 |
Why?
|
| Regional Medical Programs | 1 | 2020 | 22 | 0.190 |
Why?
|
| Patient Dropouts | 1 | 2021 | 98 | 0.190 |
Why?
|
| Blood Pressure Determination | 2 | 2018 | 152 | 0.190 |
Why?
|
| Africa, Western | 5 | 2019 | 15 | 0.180 |
Why?
|
| Intersectoral Collaboration | 1 | 2020 | 27 | 0.180 |
Why?
|
| Drug Monitoring | 1 | 2021 | 107 | 0.180 |
Why?
|
| Professional Role | 1 | 2021 | 80 | 0.180 |
Why?
|
| Developing Countries | 2 | 2018 | 106 | 0.180 |
Why?
|
| Marriage | 1 | 2020 | 30 | 0.180 |
Why?
|
| Hospital Administration | 1 | 2020 | 43 | 0.180 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 59 | 0.180 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2017 | 300 | 0.180 |
Why?
|
| Prescription Drug Monitoring Programs | 1 | 2021 | 34 | 0.180 |
Why?
|
| Spouse Abuse | 1 | 2020 | 40 | 0.180 |
Why?
|
| Tobacco Products | 2 | 2020 | 234 | 0.180 |
Why?
|
| Postoperative Complications | 2 | 2020 | 1615 | 0.180 |
Why?
|
| Quality Improvement | 2 | 2022 | 413 | 0.180 |
Why?
|
| Brain Mapping | 2 | 2020 | 532 | 0.180 |
Why?
|
| Teaching | 2 | 2013 | 169 | 0.180 |
Why?
|
| Spouses | 1 | 2020 | 51 | 0.180 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2013 | 148 | 0.180 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 1465 | 0.180 |
Why?
|
| Sentinel Surveillance | 1 | 2020 | 20 | 0.180 |
Why?
|
| Forecasting | 2 | 2019 | 277 | 0.180 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 3259 | 0.170 |
Why?
|
| Tonsillectomy | 1 | 2021 | 69 | 0.170 |
Why?
|
| Glycemic Index | 2 | 2017 | 28 | 0.170 |
Why?
|
| Social Support | 4 | 2014 | 423 | 0.170 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2019 | 18 | 0.170 |
Why?
|
| Biological Science Disciplines | 1 | 2019 | 2 | 0.170 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2019 | 54 | 0.170 |
Why?
|
| Africa South of the Sahara | 2 | 2016 | 25 | 0.170 |
Why?
|
| Self Efficacy | 3 | 2014 | 199 | 0.170 |
Why?
|
| Clostridium Infections | 1 | 2020 | 52 | 0.170 |
Why?
|
| Echocardiography | 2 | 2019 | 515 | 0.160 |
Why?
|
| Facial Recognition | 1 | 2019 | 13 | 0.160 |
Why?
|
| Patient Transfer | 1 | 2020 | 86 | 0.160 |
Why?
|
| Disposable Equipment | 1 | 2018 | 12 | 0.160 |
Why?
|
| Calcinosis | 2 | 2011 | 241 | 0.160 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2019 | 25 | 0.160 |
Why?
|
| Registries | 7 | 2018 | 733 | 0.160 |
Why?
|
| Diabetes Complications | 2 | 2018 | 249 | 0.160 |
Why?
|
| Ethnology | 1 | 2018 | 5 | 0.160 |
Why?
|
| Episode of Care | 1 | 2018 | 12 | 0.160 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2017 | 106 | 0.160 |
Why?
|
| Medication Therapy Management | 1 | 2018 | 32 | 0.160 |
Why?
|
| Biological Specimen Banks | 2 | 2019 | 38 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2017 | 536 | 0.160 |
Why?
|
| Africa | 4 | 2020 | 41 | 0.160 |
Why?
|
| Endpoint Determination | 1 | 2018 | 82 | 0.160 |
Why?
|
| Machine Learning | 1 | 2020 | 170 | 0.160 |
Why?
|
| Sensitivity and Specificity | 9 | 2014 | 1753 | 0.150 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 83 | 0.150 |
Why?
|
| Pilot Projects | 6 | 2018 | 1342 | 0.150 |
Why?
|
| Confidence Intervals | 4 | 2012 | 242 | 0.150 |
Why?
|
| Cross Infection | 1 | 2020 | 195 | 0.150 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 298 | 0.150 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 209 | 0.150 |
Why?
|
| Critical Illness | 2 | 2010 | 191 | 0.150 |
Why?
|
| Apolipoprotein L1 | 1 | 2017 | 16 | 0.150 |
Why?
|
| Age Factors | 6 | 2020 | 1864 | 0.150 |
Why?
|
| Connectome | 1 | 2019 | 92 | 0.150 |
Why?
|
| Contrast Media | 5 | 2014 | 595 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 240 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2020 | 402 | 0.150 |
Why?
|
| Reproducibility of Results | 9 | 2015 | 2077 | 0.150 |
Why?
|
| Mentoring | 1 | 2018 | 53 | 0.150 |
Why?
|
| Quality of Life | 4 | 2020 | 1515 | 0.150 |
Why?
|
| Software | 3 | 2015 | 418 | 0.140 |
Why?
|
| Practice Patterns, Nurses' | 1 | 2017 | 16 | 0.140 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 89 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 161 | 0.140 |
Why?
|
| Anxiety | 1 | 2020 | 422 | 0.140 |
Why?
|
| Ambulatory Care | 2 | 2020 | 340 | 0.140 |
Why?
|
| Models, Theoretical | 3 | 2018 | 384 | 0.140 |
Why?
|
| No-Show Patients | 1 | 2016 | 9 | 0.140 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 107 | 0.140 |
Why?
|
| Rural Population | 3 | 2016 | 398 | 0.140 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 232 | 0.140 |
Why?
|
| Sample Size | 3 | 2014 | 79 | 0.140 |
Why?
|
| Interleukin-6 | 2 | 2010 | 330 | 0.140 |
Why?
|
| Social Stigma | 1 | 2017 | 53 | 0.140 |
Why?
|
| Electrocardiography | 2 | 2017 | 601 | 0.140 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 318 | 0.130 |
Why?
|
| Nurse's Role | 1 | 2016 | 66 | 0.130 |
Why?
|
| Steroids | 1 | 2016 | 84 | 0.130 |
Why?
|
| Neuroimaging | 1 | 2017 | 122 | 0.130 |
Why?
|
| Multilingualism | 1 | 2015 | 14 | 0.130 |
Why?
|
| Phenotype | 2 | 2017 | 947 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 481 | 0.130 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2015 | 29 | 0.130 |
Why?
|
| Thrombophilia | 1 | 2015 | 21 | 0.130 |
Why?
|
| Patient Readmission | 2 | 2015 | 267 | 0.130 |
Why?
|
| Insulin | 4 | 2012 | 619 | 0.130 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2015 | 28 | 0.130 |
Why?
|
| Gray Matter | 1 | 2016 | 57 | 0.130 |
Why?
|
| Utilization Review | 1 | 2015 | 48 | 0.130 |
Why?
|
| Salmonella | 1 | 2015 | 20 | 0.130 |
Why?
|
| Video Recording | 2 | 2019 | 145 | 0.130 |
Why?
|
| Normal Distribution | 1 | 2015 | 46 | 0.130 |
Why?
|
| Absenteeism | 1 | 2015 | 27 | 0.130 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 114 | 0.130 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 121 | 0.120 |
Why?
|
| Temporal Lobe | 1 | 2016 | 125 | 0.120 |
Why?
|
| Kidney Tubules | 1 | 2015 | 80 | 0.120 |
Why?
|
| Disabled Persons | 1 | 2015 | 94 | 0.120 |
Why?
|
| Heart Rate | 1 | 2017 | 568 | 0.120 |
Why?
|
| Risk Adjustment | 1 | 2015 | 49 | 0.120 |
Why?
|
| Prostatic Neoplasms | 2 | 2018 | 778 | 0.120 |
Why?
|
| Transportation of Patients | 1 | 2015 | 46 | 0.120 |
Why?
|
| Frontal Lobe | 1 | 2016 | 156 | 0.120 |
Why?
|
| Global Health | 1 | 2015 | 136 | 0.120 |
Why?
|
| Stress, Psychological | 4 | 2018 | 824 | 0.120 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 84 | 0.120 |
Why?
|
| Thrombosis | 1 | 2015 | 218 | 0.120 |
Why?
|
| Psychotherapy | 1 | 2016 | 253 | 0.120 |
Why?
|
| Risk | 2 | 2017 | 563 | 0.120 |
Why?
|
| Research Design | 4 | 2016 | 729 | 0.110 |
Why?
|
| Learning | 2 | 2013 | 186 | 0.110 |
Why?
|
| Image Enhancement | 2 | 2012 | 143 | 0.110 |
Why?
|
| Child, Preschool | 5 | 2021 | 3187 | 0.110 |
Why?
|
| Intention | 1 | 2014 | 80 | 0.110 |
Why?
|
| Culture | 1 | 2013 | 75 | 0.110 |
Why?
|
| Radiographic Image Enhancement | 3 | 2009 | 208 | 0.110 |
Why?
|
| Educational Status | 4 | 2018 | 273 | 0.110 |
Why?
|
| Audiovisual Aids | 1 | 2013 | 20 | 0.110 |
Why?
|
| Penicillins | 1 | 2013 | 32 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 191 | 0.110 |
Why?
|
| Drug Hypersensitivity | 1 | 2013 | 35 | 0.110 |
Why?
|
| Hospitals, Teaching | 1 | 2013 | 65 | 0.110 |
Why?
|
| Infant, Newborn | 5 | 2021 | 2455 | 0.110 |
Why?
|
| Disability Evaluation | 3 | 2020 | 298 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2017 | 1040 | 0.110 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 174 | 0.100 |
Why?
|
| Anticonvulsants | 1 | 2014 | 223 | 0.100 |
Why?
|
| Alcoholism | 1 | 2021 | 1109 | 0.100 |
Why?
|
| Pattern Recognition, Automated | 2 | 2009 | 70 | 0.100 |
Why?
|
| Delayed Graft Function | 3 | 2016 | 39 | 0.100 |
Why?
|
| Tissue Donors | 1 | 2014 | 195 | 0.100 |
Why?
|
| Anatomy | 1 | 2013 | 36 | 0.100 |
Why?
|
| Weight Gain | 1 | 2013 | 135 | 0.100 |
Why?
|
| Auditory Perception | 1 | 2013 | 89 | 0.100 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2012 | 22 | 0.100 |
Why?
|
| Students, Medical | 2 | 2013 | 210 | 0.100 |
Why?
|
| Mental Health | 1 | 2014 | 278 | 0.100 |
Why?
|
| Genotype | 3 | 2017 | 786 | 0.100 |
Why?
|
| Behavior, Addictive | 1 | 2015 | 317 | 0.100 |
Why?
|
| Functional Neuroimaging | 1 | 2012 | 82 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 772 | 0.100 |
Why?
|
| Iohexol | 1 | 2012 | 82 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2012 | 111 | 0.100 |
Why?
|
| Prescriptions | 1 | 2011 | 28 | 0.100 |
Why?
|
| Random Allocation | 1 | 2012 | 442 | 0.100 |
Why?
|
| Uganda | 2 | 2021 | 41 | 0.100 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 166 | 0.100 |
Why?
|
| Feasibility Studies | 3 | 2018 | 652 | 0.090 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2010 | 4 | 0.090 |
Why?
|
| Prisons | 1 | 2010 | 18 | 0.090 |
Why?
|
| Southeastern United States | 3 | 2018 | 281 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 181 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2012 | 117 | 0.090 |
Why?
|
| Survivors | 3 | 2018 | 256 | 0.090 |
Why?
|
| Kidney | 1 | 2015 | 945 | 0.090 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2012 | 142 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 286 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 237 | 0.090 |
Why?
|
| Colorectal Surgery | 1 | 2009 | 11 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 103 | 0.090 |
Why?
|
| Biostatistics | 1 | 2010 | 43 | 0.090 |
Why?
|
| SEER Program | 3 | 2018 | 153 | 0.090 |
Why?
|
| Program Evaluation | 2 | 2010 | 502 | 0.080 |
Why?
|
| Fasting | 1 | 2009 | 75 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 301 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2019 | 468 | 0.080 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2009 | 60 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2009 | 81 | 0.080 |
Why?
|
| Life Expectancy | 1 | 2009 | 51 | 0.080 |
Why?
|
| Sarcoidosis | 1 | 2009 | 77 | 0.080 |
Why?
|
| Single-Blind Method | 2 | 2021 | 249 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 274 | 0.080 |
Why?
|
| Violence | 1 | 2010 | 275 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2021 | 3705 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 160 | 0.080 |
Why?
|
| Psychometrics | 1 | 2011 | 514 | 0.080 |
Why?
|
| Ventricular Function, Right | 1 | 2009 | 103 | 0.080 |
Why?
|
| Text Messaging | 2 | 2019 | 47 | 0.080 |
Why?
|
| Pregnancy in Adolescence | 1 | 2008 | 33 | 0.080 |
Why?
|
| Pneumonectomy | 1 | 2008 | 79 | 0.080 |
Why?
|
| Age Distribution | 3 | 2015 | 320 | 0.080 |
Why?
|
| Databases, Factual | 3 | 2017 | 622 | 0.070 |
Why?
|
| Life Style | 1 | 2010 | 338 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 167 | 0.070 |
Why?
|
| Louisiana | 2 | 2018 | 37 | 0.070 |
Why?
|
| Genetic Research | 2 | 2019 | 16 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 172 | 0.070 |
Why?
|
| Marital Status | 2 | 2018 | 65 | 0.070 |
Why?
|
| Maternal Age | 2 | 2020 | 70 | 0.070 |
Why?
|
| Plasmacytoma | 1 | 2006 | 15 | 0.070 |
Why?
|
| Family | 1 | 2009 | 293 | 0.070 |
Why?
|
| Schools | 1 | 2008 | 156 | 0.070 |
Why?
|
| Body Mass Index | 3 | 2020 | 867 | 0.070 |
Why?
|
| Infant | 3 | 2021 | 2891 | 0.070 |
Why?
|
| Hospital Mortality | 2 | 2020 | 384 | 0.070 |
Why?
|
| Internationality | 2 | 2016 | 74 | 0.070 |
Why?
|
| Focus Groups | 2 | 2018 | 247 | 0.060 |
Why?
|
| Clinical Protocols | 2 | 2016 | 172 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2004 | 91 | 0.060 |
Why?
|
| Qualitative Research | 2 | 2018 | 369 | 0.060 |
Why?
|
| Genome, Human | 1 | 2004 | 62 | 0.060 |
Why?
|
| Exercise | 3 | 2014 | 658 | 0.060 |
Why?
|
| Health Education | 2 | 2018 | 279 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 561 | 0.060 |
Why?
|
| Length of Stay | 2 | 2020 | 780 | 0.060 |
Why?
|
| Social Environment | 2 | 2014 | 182 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2023 | 87 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2017 | 689 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 546 | 0.050 |
Why?
|
| CTLA-4 Antigen | 1 | 2022 | 45 | 0.050 |
Why?
|
| Bupropion | 1 | 2022 | 63 | 0.050 |
Why?
|
| Appendectomy | 1 | 2022 | 47 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2023 | 174 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2017 | 782 | 0.050 |
Why?
|
| Medication Reconciliation | 1 | 2021 | 18 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 87 | 0.050 |
Why?
|
| Motivation | 2 | 2016 | 561 | 0.050 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2021 | 26 | 0.050 |
Why?
|
| Controlled Substances | 1 | 2021 | 5 | 0.050 |
Why?
|
| Stakeholder Participation | 1 | 2020 | 17 | 0.050 |
Why?
|
| Sex Distribution | 2 | 2015 | 274 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2012 | 411 | 0.050 |
Why?
|
| Perception | 2 | 2013 | 189 | 0.050 |
Why?
|
| Gender Identity | 1 | 2020 | 47 | 0.050 |
Why?
|
| Medication Errors | 1 | 2021 | 116 | 0.040 |
Why?
|
| Alcohol Drinking | 2 | 2021 | 805 | 0.040 |
Why?
|
| North Carolina | 1 | 2020 | 224 | 0.040 |
Why?
|
| Florida | 1 | 2020 | 221 | 0.040 |
Why?
|
| Token Economy | 1 | 2019 | 12 | 0.040 |
Why?
|
| Educational Measurement | 2 | 2013 | 254 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 114 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 214 | 0.040 |
Why?
|
| Kenya | 1 | 2019 | 26 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2015 | 504 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2019 | 46 | 0.040 |
Why?
|
| APACHE | 2 | 2010 | 41 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2010 | 219 | 0.040 |
Why?
|
| Clergy | 1 | 2018 | 7 | 0.040 |
Why?
|
| Systole | 1 | 2019 | 149 | 0.040 |
Why?
|
| Hospitals, Private | 1 | 2018 | 15 | 0.040 |
Why?
|
| Rest | 1 | 2019 | 78 | 0.040 |
Why?
|
| Hospitals, Public | 1 | 2018 | 22 | 0.040 |
Why?
|
| Emotions | 1 | 2020 | 244 | 0.040 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2018 | 54 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2018 | 110 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2021 | 294 | 0.040 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 53 | 0.040 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2018 | 76 | 0.040 |
Why?
|
| Overweight | 1 | 2020 | 186 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 1536 | 0.040 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2018 | 10 | 0.040 |
Why?
|
| Spatial Analysis | 1 | 2018 | 33 | 0.040 |
Why?
|
| Urban Population | 2 | 2011 | 255 | 0.040 |
Why?
|
| Intracranial Embolism | 1 | 2018 | 25 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2017 | 7 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 4 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 281 | 0.040 |
Why?
|
| Curriculum | 2 | 2013 | 575 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 51 | 0.040 |
Why?
|
| Vegetables | 1 | 2018 | 76 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 99 | 0.040 |
Why?
|
| Stroke, Lacunar | 1 | 2017 | 3 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2010 | 344 | 0.040 |
Why?
|
| Developed Countries | 1 | 2016 | 8 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2019 | 324 | 0.040 |
Why?
|
| Nerve Net | 1 | 2019 | 181 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2016 | 36 | 0.040 |
Why?
|
| Withholding Treatment | 1 | 2016 | 35 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 658 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 2016 | 47 | 0.030 |
Why?
|
| Mycophenolic Acid | 1 | 2016 | 62 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 99 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2017 | 183 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 513 | 0.030 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2018 | 134 | 0.030 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2017 | 116 | 0.030 |
Why?
|
| Decision Making | 1 | 2019 | 410 | 0.030 |
Why?
|
| Genomics | 1 | 2017 | 168 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 136 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 2015 | 22 | 0.030 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2015 | 10 | 0.030 |
Why?
|
| Cultural Characteristics | 1 | 2015 | 42 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2016 | 104 | 0.030 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2015 | 25 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2018 | 276 | 0.030 |
Why?
|
| Models, Econometric | 1 | 2015 | 26 | 0.030 |
Why?
|
| Autoantigens | 1 | 2015 | 91 | 0.030 |
Why?
|
| Atrophy | 1 | 2015 | 112 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 239 | 0.030 |
Why?
|
| Employment | 1 | 2016 | 154 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 124 | 0.030 |
Why?
|
| Caregivers | 1 | 2018 | 365 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2008 | 800 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 133 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1038 | 0.030 |
Why?
|
| Nursing Homes | 1 | 2015 | 54 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2016 | 240 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2015 | 204 | 0.030 |
Why?
|
| Diet | 1 | 2018 | 514 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 238 | 0.030 |
Why?
|
| Health Literacy | 1 | 2014 | 63 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 529 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2014 | 201 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 392 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 193 | 0.030 |
Why?
|
| Trust | 1 | 2014 | 75 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 219 | 0.030 |
Why?
|
| Skin Tests | 1 | 2013 | 30 | 0.030 |
Why?
|
| Neuroanatomy | 1 | 2013 | 14 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 253 | 0.030 |
Why?
|
| Informed Consent | 1 | 2014 | 127 | 0.030 |
Why?
|
| Recurrence | 1 | 2015 | 948 | 0.030 |
Why?
|
| Students, Dental | 1 | 2013 | 49 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2014 | 224 | 0.030 |
Why?
|
| Patient Participation | 1 | 2013 | 146 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2012 | 42 | 0.030 |
Why?
|
| Polysomnography | 1 | 2012 | 92 | 0.030 |
Why?
|
| Gestational Age | 1 | 2013 | 389 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2012 | 117 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2014 | 343 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2012 | 133 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 90 | 0.020 |
Why?
|
| Self Report | 1 | 2013 | 371 | 0.020 |
Why?
|
| Ventricular Function | 1 | 2012 | 93 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1738 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1745 | 0.020 |
Why?
|
| Health Status | 1 | 2013 | 429 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2014 | 374 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2010 | 80 | 0.020 |
Why?
|
| Comprehension | 1 | 2010 | 71 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 807 | 0.020 |
Why?
|
| Poverty Areas | 1 | 2009 | 20 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 2009 | 12 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2014 | 657 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2010 | 157 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2012 | 586 | 0.020 |
Why?
|
| Energy Intake | 1 | 2010 | 123 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 649 | 0.020 |
Why?
|
| Iopamidol | 1 | 2009 | 37 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2009 | 114 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2009 | 99 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2010 | 180 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 306 | 0.020 |
Why?
|
| Movement | 1 | 2009 | 179 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 245 | 0.020 |
Why?
|
| Internet | 1 | 2010 | 390 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 159 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 333 | 0.020 |
Why?
|
| Los Angeles | 1 | 2006 | 30 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2006 | 220 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1174 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 1667 | 0.010 |
Why?
|